N@N

William Pickering Initiated (BMRN) at Sell and Held Target at $81 on, Mar 21st, 2023

William Pickering of Bernstein, Initiated "BioMarin Pharmaceutical Inc." (BMRN) at Sell and Held Target at $81 on, Mar 21st, 2023.

William has made no other calls on BMRN in the last 4 months.

There are 11 other peers that have a rating on BMRN. Out of the 11 peers that are also analyzing BMRN, 5 agree with William's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• Kostas Biliouris of "BMO Capital" Maintained at Hold with Decreased Target to $102 on, Tuesday, March 7th, 2023
• Andreas Argyrides of "Wedbush" Maintained at Hold with Decreased Target to $74 on, Tuesday, February 28th, 2023
• Whitney Ijem of "Canaccord Genuity" Maintained at Hold with Decreased Target to $112 on, Tuesday, February 28th, 2023
• Leland Gershell of "Oppenheimer" Downgraded from Buy to Hold on, Wednesday, February 22nd, 2023
• David Lebowitz of "Citigroup" Initiated at Hold and Held Target at $116 on, Tuesday, February 21st, 2023

These are the ratings of the 6 analyists that currently disagree with William

---

• Debjit Chattopadhyay of "Guggenheim" Reiterated at Strong Buy and Held Target at $125 on, Tuesday, February 28th, 2023
• Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $131 on, Tuesday, February 28th, 2023
• Paul Matteis of "Stifel" Maintained at Strong Buy with Increased Target to $118 on, Tuesday, February 28th, 2023
• Tiago Fauth of "Credit Suisse" Maintained at Buy with Increased Target to $127 on, Tuesday, February 28th, 2023
• Joseph Schwartz of "SVB Leerink" Maintained at Buy with Increased Target to $130 on, Friday, February 3rd, 2023
• Akash Tewari of "Jefferies" Maintained at Strong Buy with Increased Target to $120 on, Tuesday, November 29th, 2022

Contributing Sources

---